Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: Final results of a noninterventional study

Chia sẻ: _ _ | Ngày: | Loại File: PDF | Số trang:10

Thêm vào BST

Báo xấu

14
lượt xem 0
download

Download Vui lòng tải xuống để xem tài liệu đầy đủ

Data are limited regarding routine use of everolimus after initial vascular endothelial growth factor (VEGF)–targeted therapy. The aim of this prospective, noninterventional, observational study was to assess efficacy and safety of everolimus after initial VEGF-targeted treatment in patients with metastatic renal cell carcinoma (mRCC) in routine clinical settings.

Chủ đề: